Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (TSX:BHC)

9.530 +0.280 (+3.03%)
Streaming Delayed Price Updated: 9:48 AM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 Next >
Bausch Health Announces Third Quarter 2025 Results
Via ACCESS Newswire
Bausch Health Announces Results of Special Meeting of Shareholders
Via ACCESS Newswire
Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV
Via ACCESS Newswire
Bausch Health to Announce Third Quarter 2025 Results on October 29
Via ACCESS Newswire
Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
Via ACCESS Newswire
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
Via ACCESS Newswire
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
Via ACCESS Newswire
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
Via ACCESS Newswire
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes
Via ACCESS Newswire
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners
Via ACCESS Newswire
Bausch Health Announces Second Quarter 2025 Results
Via ACCESS Newswire
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
Via ACCESS Newswire
Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand
Via ACCESS Newswire
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
Via ACCESS Newswire
Bausch Health Appoints New Chief Accounting Officer
Via ACCESS Newswire
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
Via ACCESS Newswire
Bausch Health to Announce Second Quarter 2025 Results on July 30
Via ACCESS Newswire
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
Via ACCESS Newswire
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
Via ACCESS Newswire
Bausch Health Announces First Quarter 2025 Results
Via ACCESS Newswire
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
Via ACCESS Newswire
Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)
Via ACCESS Newswire
Bausch Health Announces Filing of Supplement to Proxy Statement
Via ACCESS Newswire
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
Via ACCESS Newswire
Bausch Health Announces Adoption of Shareholder Rights Plan
Via ACCESS Newswire
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Via ACCESS Newswire
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Via ACCESS Newswire
Bausch Health to Announce First Quarter Results on April 30
Via ACCESS Newswire
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
Via ACCESS Newswire
Bausch Health Announces Conditional Redemption of Senior Notes
Via ACCESS Newswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.